Target intelligence / Profile preview

C-type lectin domain family 1, member B pseudogene (CLEC1B pseudogene (no officially recognized abbreviation))

Target
CLEC1B pseudogene (no officially recognized abbreviation)
Molecular classification
Other (pseudogene; not a protein-coding gene)
01

Overview

C-type lectin domain family 1, member B pseudogene (ENSG00000256626, also known as LOC100421202) is a classified pseudogene within the C-type lectin domain family. Unlike its functional paralog CLEC1B—which encodes a transmembrane receptor involved in platelet activation, immune response, and pathogen recognition—this pseudogene does not code for a protein and has no established biological or therapeutic activity. Pseudogenes arise by duplication or retrotransposition of functional genes but typically lack protein-coding capacity due to sequence disruptions. As such, this locus should not be considered a molecular target for drug development or disease intervention[3][1]. If a molecular target is required, information should be sought for the closely related C-type lectin domain family 1 member B (CLEC1B, gene symbol: CLEC1B), which is a bona fide receptor with immunological functions, not for the pseudogene.

Other names
LOC100421202C-type lectin domain family 1 member B pseudogeneENSG00000256626
02

Mechanism of action

None (not a protein, so it cannot be pharmacologically modulated)

03

Biological functions

No known biological functions (pseudogene; does not encode a protein)
04

Disease associations

None (pseudogenes generally do not have a direct role in disease, unless acting via regulatory/non-coding RNA effects, which is not established for this pseudogene)
05

Safety considerations

None described (pseudogenes themselves do not pose specific safety concerns in a therapeutic context)
06

Interacting drugs

None (not a functional protein/receptor/enzyme)
07

Biomarkers

None known (not in use as a clinical biomarker)

Beyond the preview

Go deeper on C-type lectin domain family 1, member B pseudogene (CLEC1B pseudogene (no officially recognized abbreviation)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on C-type lectin domain family 1, member B pseudogene (CLEC1B pseudogene (no officially recognized abbreviation)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call